Medicated Skin Care in the United Kingdom

June 2012 | 41 pages | ID: M0CEAEDB06AEN
Euromonitor International Ltd

Abstracts

Sales of medicated skin care declined marginally in 2011, to £285 million. Paediatric medicated skin care and hair loss treatments were the fastest growing categories, as sales increased by 6% and 4%, respectively. Topical allergy remedies/antihistamines and antipruritics and antipruritics were the only other categories to see growth of over 2%.

Euromonitor International's Medicated Skin Care in United Kingdom report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Medicated Skin Care market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares by Value 2008-2011
  Table 5 Hair Loss Treatments Brand Shares by Value 2008-2011
  Table 6 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 7 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Boots UK Ltd in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
  Summary 1 Boots UK Ltd: Key Facts
  Summary 2 Boots UK Ltd: Operational Indicators
Company Background
Production
  Summary 3 BCM: Production Statistics 2011
Competitive Positioning
  Summary 4 Boots UK Ltd: Competitive Position 2011
Forest Laboratories UK Ltd in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
  Summary 5 Forest Laboratories UK Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 6 Forest Laboratories UK Ltd: Competitive Position 2011
GlaxoSmithKline Plc in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
  Summary 7 GlaxoSmithKline Plc: Key Facts
Company Background
Production
Competitive Positioning
  Summary 8 GlaxoSmithKline Plc: Competitive Position 2011
Mcneil Healthcare (uk) Ltd in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
  Summary 9 McNeil UK Healthcare Ltd: Key Facts
Company Background
Production
Competitive Positioning
  Summary 10 McNeil Healthcare UK Ltd: Competitive Position 2011
Reckitt Benckiser Plc in Consumer Health (united Kingdom)
Strategic Direction
Key Facts
  Summary 11 Reckitt Benckiser Plc: Key Facts
  Summary 12 Reckitt Benckiser Plc: Operational Indicators
Company Background
Production
  Summary 13 Reckitt Benckiser Plc: Production Statistics 2011
Competitive Positioning
  Summary 14 Reckitt Benckiser Plc: Competitive Position 2011
Executive Summary
Growth Despite Tough Trading Conditions and Policy Uncertainty
Sports Nutrition Hits the Mainstream While Other Categories Return To the Margins
Innovation the Key for Brands To Compete With Private Label
Supermarkets and Internet Retailing Gain Share But Specialists Fight Back
Growth Picks Up Marginally Over the Forecast Period
Key Trends and Developments
Opportunities for Growth in A Dire Economic Climate
Current Impact
Outlook
Future Impact
Innovation Key for Differentiation and Market Capture
the Days of Stellar Switches Are Over (for Now)
Uncertain Outlook for Traditional Herbal Products
Promoting Responsible Self-medication: Where Profit Meets Policy
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 9 Life Expectancy at Birth 2006-2011
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2006-2011
  Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 12 Consumer Health Company Shares 2007-2011
  Table 13 Consumer Health Brand Shares 2008-2011
  Table 14 Penetration of Private Label by Category 2006-2011
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
EU Legislation
UK Environment
Self-medication/self-care and Preventative Medicine
Switches
  Summary 15 OTC Switches 2009-2011
Sources
  Summary 16 Research Sources